Visceral fat thickness determined using ultrasonography is associated with anthropometric and clinical parameters of metabolic syndrome

Basit Öğe Kaydı
dc.contributor.authorGuldiken, S.
dc.contributor.authorTuncbilek, N.
dc.contributor.authorOkten, O. O.
dc.contributor.authorArikan, E.
dc.contributor.authorTugrul, A.
dc.date.accessioned2024-06-12T11:08:23Z
dc.date.available2024-06-12T11:08:23Z
dc.date.issued2006
dc.departmentTrakya Üniversitesien_US
dc.description.abstractThe aim of this study is to find out the relation between the ultrasonographic (USG) measurements of the abdominal fat thickness and cardiovascular risk factors in metabolic syndrome. The thickness of subcutaneous fat (SF), visceral fat (VF) and preperitoneal fat (PF) was measured using USG in 75 subjects (35 women and 40 men) with metabolic syndrome. The body mass index (BMI), waist circumference (WC), systolic (SBP) and diastolic (DBP) blood pressures, fasting plasma glucose, fasting insulin and lipid parameters of all participants were recorded. Insulin resistance was estimated using HOMA-IR formula. BMI (p < 0.05), WC (p < 0.01), SBP (p < 0.001), DBP (p < 0.05), fasting insulin (p < 0.05), total cholesterol (p < 0.001) and triglyceride (p < 0.001) levels were found in correlation with VF thickness in the female group. There was a positive association between WC and SF thickness (p < 0.05) in the same group. In the male patients, BMI (p < 0.001), WC (p < 0.01), SBP (p < 0.05), DBP (p < 0.05) and triglyceride level (p = 0.01) were significantly correlated with VF thickness. SF thickness was associated with BMI (p < 0.001) and WC (p < 0.01) in this group. There was no relation between PF thickness and clinical variables in both groups (p > 0.05). It can be concluded that VF thickness may have a significant pathophysiological role in the development of the metabolic syndrome.en_US
dc.identifier.doi10.1111/j.1742-1241.2005.00803.x
dc.identifier.endpage1581en_US
dc.identifier.issn1368-5031
dc.identifier.issn1742-1241
dc.identifier.issue12en_US
dc.identifier.pmid16669827en_US
dc.identifier.scopus2-s2.0-33750977260en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1576en_US
dc.identifier.urihttps://doi.org/10.1111/j.1742-1241.2005.00803.x
dc.identifier.urihttps://hdl.handle.net/20.500.14551/22404
dc.identifier.volume60en_US
dc.identifier.wosWOS:000241952200014en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofInternational Journal Of Clinical Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMetabolic Syndromeen_US
dc.subjectVisceral Fat Thicknessen_US
dc.subjectAbdominal Fat Layersen_US
dc.subjectUltrasonographyen_US
dc.subjectCardiovascular Diseaseen_US
dc.subjectAdipose-Tissue Distributionen_US
dc.subjectCardiovascular Risk-Factorsen_US
dc.subjectInsulin-Resistanceen_US
dc.subjectAbdominal Faten_US
dc.subjectBody-Faten_US
dc.subjectComputed-Tomographyen_US
dc.subjectGlucose-Toleranceen_US
dc.subjectBlood-Pressureen_US
dc.subjectObese Womenen_US
dc.subjectDiseaseen_US
dc.titleVisceral fat thickness determined using ultrasonography is associated with anthropometric and clinical parameters of metabolic syndromeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu

Kişisel bilgilerinizi şu amaçlarla toplar ve işleriz: Kimlik Doğrulama, Tercihler, Onay ve İstatistikler.
Daha fazla bilgi edinmek için lütfen gizlilik politikası sayfamızı okuyun.

Özelleştirme